Legal 500
Log in or register
  • Rankings

    • Jurisdictions
    • Submissions
    • Future Lawyers
  • Firms & Lawyers

    • Service Providers
    • Barristers’ Sets
    • Networks
    • Interview with…
  • In-House

    • In-House Content
    • GC Powerlist
  • Knowledge Centre

    • Data Products
    • Legal Business
    • Market Intelligence
    • About us

      • Legal 500
      • FAQs
      • Marketing
      • Careers
      • Trust Centre
      • Contact us
  • Comparative Guides
  • Events
  • Legal 500 TV

About us

  • Legal 500
  • FAQs
  • Marketing
  • Careers
  • Trust Centre
  • Contact us
  • Deutschland DE
  • Paris FR
  • Rankings

    • Jurisdictions
    • Submissions
    • Future Lawyers
  • Firms & Lawyers

    • Service Providers
    • Barristers’ Sets
    • Networks
    • Interview with…
  • In-House

    • In-House Content
    • GC Powerlist
  • Knowledge Centre

    • Data Products
    • Legal Business
    • Market Intelligence
    • About us

      • Legal 500
      • FAQs
      • Marketing
      • Careers
      • Trust Centre
      • Contact us
  • Comparative Guides
  • Events
  • Legal 500 TV

About us

  • Legal 500
  • FAQs
  • Marketing
  • Careers
  • Trust Centre
  • Contact us
  • Deutschland DE
  • Paris FR

© 2026 Legalease Ltd. All rights reserved

Registered company in England & Wales No. 02427356 VAT GB 321 5727 22

Registered address: 188 Fleet Street, London, EC4A 2AG

  • Legal 500 Trust Centre
  • Contact Us
  • home
  • Market Intelligence
  • Search

292 results found

Use advanced search filters to refine your search

2 filters applied

Advanced search filters

Topics
Countries
Contributor

Start typing to add contributors

Content type
Show options
  • Article

    Polymorph Applications: The Mexican Approach

    In the summer of 1998, Abbot Laboratories was forced to remove from the market a first crystalline form of its medicament ritonavir, a peptidomimetic drug used to treat HIV-1 infection, in favor of a second molecular form, or polymorph, which had different dissolution properties.
    MexicoIntellectual Property
    Becerril Coca & Becerril
    Becerril Coca & Becerril
  • Article

    México em 2016: proporcionando um ambiente de investimento amigável

    Consciente da importância que têm os direitos de PI na economia mundial, o México – num curto período de tempo - experimentou várias reformas no seu quadro jurídico, implementou mudanças de grande escala na sua estrutura ...
    MexicoIntellectual Property
    Clarke, Modet & Co
    Clarke, Modet & Co
Article

Reformas a la Ley de la Propiedad Industrial, en materia de Diseños Industriales, Marcas y Denominaciones de Origen e indicaciones geográficas

El día 13 de marzo de 2018, se publicaron en el Diario Oficial de la Federación diversas reformas a la Ley de la Propiedad Industrial, mismas que entrarán en vigor el 27 de abril de 2018.
MexicoIntellectual Property
Basham, Ringe y Correa, S.C.
Basham, Ringe y Correa, S.C.
  • Article

    Entrega De Patentes A La Benemérita Universidad Autónoma De Puebla

    El pasado 7 de Octubre de 2014 nos reunimos en el edificio Carolino de la Benemérita Universidad Autónoma de Puebla, (BUAP)...
    MexicoIntellectual Property
    Panamericana de Patents y Marcas
    Panamericana de Patents y Marcas
  • Article

    Mexico Issues Regulations To Approve Biologic Drugs

    A decree was recently published modifying several provisions of the Health Law Regulations addressing the approval of biologic drugs.
    MexicoFood, Drugs, Healthcare, Life Sciences
    Olivares
    Olivares
  • Article

    Clarke, Modet & Cº México: Metas atuais sobre PI

    O passado 28 de setembro, Clarke, Modet & Cº México celebrou em sua sede um evento para apresentar o tema "Metas atuais sobre PI" ao que foram convidados jornalistas das fontes de negócio, empreendedores, tecnologia e especializados em indústria e Propriedade Industrial e Intelectual.
    MexicoIntellectual Property
    Clarke, Modet & Co
    Clarke, Modet & Co
  • Article

    "How To Take Advantage Of Article 54 Of The Mexican Law For Facilitating The Allowance Of Mexican Patent Applications"

    MexicoIntellectual Property
    Becerril Coca & Becerril
    Becerril Coca & Becerril
  • Article

    The Final Touch For The Mexican Implementation Of The Hague Agreement

    June 6, 2020 is the date on which the Geneva Act of the Hague Agreement Concerning the International Registration of Industrial Designs will enter into force in Mexico.
    MexicoIntellectual Property
    Becerril Coca & Becerril
    Becerril Coca & Becerril
  • Article

    The Right (Legal Standing) To Claim Nullity Of A Pharma Patent

    The decree published in the Official Gazette of the Federation on Sept. 19, 2003, added section IV of article 167 and article 167 bis of the Health Supplies Regulation...
    MexicoIntellectual Property
    Olivares
    Olivares
  • Article

    La propiedad intelectual detrás de un gadget

    Este artículo se publicó previamente en la revista Entrepreneur, Vol. 26, No. 4, Abril de 2018.
    MexicoIntellectual Property
    Becerril Coca & Becerril
    Becerril Coca & Becerril
  • Article

    Mexico And China, Different Perspectives On Innovation

    Let us make a brief comparison between the Mexican and Chinese IP system results
    GlobalIntellectual Property
    Clarke, Modet & Co
    Clarke, Modet & Co
  • Article

    Current Challenges In Mexican Patent Practice: Divisional Applications And Double Patenting

    Since our current IP law (LFPPI) entered into force on November 5, 2020, we have seen several positive changes in Mexican patent practice.
    MexicoIntellectual Property
    Olivares
    Olivares
  • Article

    Health & Patent Rights During The COVID-19 Pandemic

    There is no doubt that COVID-19 has impacted almost every aspect of our lives. Due to the ongoing health crisis, among other efforts, governments have implemented measures...
    MexicoIntellectual Property
    Olivares
    Olivares
  • Article

    Second Medical Use Claims In Mexico With The New European Format

    It is widely known that the methods for the treatment of the human or animal body by means of therapy are excluded from patentability in most legislations around the world, and the Mexican law is not the exception.
    MexicoIntellectual Property
    Becerril Coca & Becerril
    Becerril Coca & Becerril
  • Article

    O Convênio de Diversidade Biológica e sua aplicação na legislação mexicana

    Como país megadiverso, o México reconhece o valor da diversidade biológica pela assinatura do Convênio de Diversidade Biológica (CDB).
    MexicoFood, Drugs, Healthcare, Life Sciences
    Clarke, Modet & Co
    Clarke, Modet & Co
  • Article

    The Convention On Biological Diversity And Its Implementation Within The Mexican Law

    The CBD has protocols for to help carrying out its implementation.
    MexicoIntellectual Property
    Clarke, Modet & Co
    Clarke, Modet & Co
  • Article

    El Día Mundial de la Propiedad Intelectual

    Este artículo se publicó previamente en la revista ENTREPRENEUR, Vol. 26, No. 5, Mayo de 2018.
    MexicoIntellectual Property
    Becerril Coca & Becerril
    Becerril Coca & Becerril
  • Article

    México en el 2016: propiciando un entorno de inversión amigable

    Consciente de la importancia que tienen los derechos de PI en la economía mundial, México
    MexicoIntellectual Property
    Clarke, Modet & Co
    Clarke, Modet & Co
  • Article

    Do New Medicine Procurement Rules Violate Constitution?

    Within the framework of the agreement that the Health Institute for Welfare (INSABI) signed with the UN Office for Project Services (UNOPS) for the procurement of medicines for the public...
    MexicoGovernment, Public Sector
    Olivares
    Olivares
  • Article

    An Unfortunate Situation For Divisional Applications In Mexico

    Divisional applications are excellent for protecting additional embodiments of an invention. In many technology fields, and especially in the pharmaceutical industry...
    MexicoIntellectual Property
    Olivares
    Olivares
  • Showing 161–180 of 292 results

    PreviousNext
    Legal Intelligence Newsletters: sign up for the latest legal and regulatory news on your chosen topics